CRISCuris, Inc.

$14M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-3.1% YoY

Gross Profit

$2M94.9% margin

Operating Income

-$11M-465.9% margin

Net Income

-$11M-474.1% margin

EPS (Diluted)

$-2.37

QoQ Revenue Growth

+4.4%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$181M

Total Liabilities

$69M

Stockholders' Equity

$112M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-3.1%
Gross Profit	$2M	$2M	-3.0%
Operating Income	-$11M	-$5M	-96.1%
Net Income	-$11M	-$7M	-61.6%

Revenue Segments

Gross Royalty Revenue

$2M103%

Other Revenue

$1,0000%

Contra Revenue

-$63,000-3%

CRIS Q2 2021 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena